Showing results (1211-1220 of 1,293) with videos related to

Sort By:
Pageof 130
BMC Medical Research Methodology|February 28, 2025
Handling of missing component information for common composite score outcomes used in axial spondyloarthritis research when complete-case analysis is unbiasedChristos Polysopoulos, Stylianos Georgiadis, Lykke Midtbøll Ørnbjerg, et al.
Multiple Sclerosis and Related Disorders|November 29, 2025
Non-inferiority of Rituximab versus OCrelizumab in Multiple Sclerosis (ROC-MS)-an individual participant data meta-analysisLisa G Schoof, Brit Ellen Rød, Sahla El Mahdaoui, et al.
Ebiomedicine|May 3, 2022
Interleukin-6 inhibition in ST-elevation myocardial infarction: Immune cell profile in the randomised ASSAIL-MI trialCamilla Huse, Anne Kristine Anstensrud, Annika E Michelsen, et al.
Atherosclerosis|December 25, 2019
Legumain is upregulated in acute cardiovascular events and associated with improved outcome - potentially related to anti-inflammatory effects on macrophagesNgoc Nguyen Lunde, Ida Gregersen, Thor Ueland, et al.
BMC Rheumatology|July 2, 2025
Interchangeability of patient pain, fatigue and global scores in patients with spondyloarthritis - a registry-based simulation studyStylianos Georgiadis, Daniela Di Giuseppe, Almut Scherer, et al.
RMD Open|February 20, 2025
Challenge of missing data in observational studies: investigating cross-sectional imputation methods for assessing disease activity in axial spondyloarthritisStylianos Georgiadis, Marion Pons, Simon Rasmussen, et al.
The Journal of Allergy and Clinical Immunology|September 24, 2020
Elevated plasma sTIM-3 levels in patients with severe COVID-19Thor Ueland, Lars Heggelund, Andreas Lind, et al.
Journal of Medicinal Chemistry|January 11, 2014
Small molecule disruptors of the glucokinase-glucokinase regulatory protein interaction: 2. Leveraging structure-based drug design to identify analogues with improved pharmacokinetic profilesDavid J St Jean, Kate S Ashton, Michael D Bartberger, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Persistent interferon signaling and clonal expansion mark early events in DNA methylation damage-induced liver cancerLee J Pribyl, Jennifer E Kay, Joshua J Corrigan, et al.
Arthritis Care & Research|June 26, 2024
Comparing DAPSA, DAPSA28, and DAS28-CRP in Patients With Psoriatic Arthritis Initiating a First Tumor Necrosis Factor Inhibitor Across Nine European CountriesLouise Linde, Stylianos Georgiadis, Lykke M Ørnbjerg, et al.
Pageof 130